Rituximab and plasmapheresis for severe post-transplant auto-immune hepatitis

Clin Res Hepatol Gastroenterol. 2022 Mar;46(3):101844. doi: 10.1016/j.clinre.2021.101844. Epub 2021 Dec 15.
No abstract available

Keywords: Auto-immune hepatitis; Liver transplantation; Plasmapheresis; Rituximab; Treatment.

Publication types

  • Letter

MeSH terms

  • Graft Rejection
  • Hepatitis*
  • Humans
  • Plasmapheresis*
  • Rituximab / therapeutic use
  • Treatment Outcome

Substances

  • Rituximab